Court approves Bayer settlement over Roundup
The German manufacturer may pay 7.25 billion dollars to US users who have filed cancer claims.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
A judge in Missouri on Friday approved a settlement under which Bayer seeks to resolve years of ongoing and future US lawsuits over the weedkiller Roundup. The amount could rise to 7.25 billion dollars and will be paid over a period of up to 21 years.
The agreement applies to thousands of users who say that Roundup, whose active ingredient is glyphosate, caused non-Hodgkin lymphoma. According to the news agency, people who used the product previously and are diagnosed with the disease in future may also be able to participate, subject to conditions. According to Associated Press, the average compensation is expected to range from 10,000 to 165,000 dollars, depending among other things on age, exposure and the severity of the illness.
According to Bayer, the arrangement comes on top of previous payments and provisions for Roundup cases. In its third-quarter financial report, the company says that Monsanto, Roundup’s former owner, will make declining annual payments into a fund. Bayer says the total contribution could amount to 7.25 billion dollars; the term will be between 17 and 21 years.
The judge also approved up to 600 million dollars in legal fees. According to the ruling, the proposed average payouts were sufficient and the total amount ranks among the largest settlements in US mass personal-injury claims. The decision can still be appealed, meaning that implementation is not yet fully certain.
Bayer says the settlement does not constitute an admission of legal liability. The company says scientific studies and regulators consider Roundup safe when used as directed. The US Environmental Protection Agency (EPA) writes that its 2017 risk assessment found no concerning cancer risk and that a new assessment is expected in 2026.
On the other hand, the World Health Organization’s cancer research agency IARC classified glyphosate in 2015 as ‘probably carcinogenic to humans’. That classification and regulators’ assessments do not answer exactly the same question: IARC assesses potential hazard, while regulators also consider exposure and conditions of use.
The legal scope for new claims has also changed. According to AP, the US Supreme Court ruled in June that states cannot impose an additional duty to warn about cancer when federal rules do not require such a warning. That restriction may make a settlement more attractive to some claimants.
For Bayer, the agreement offers greater predictability over a case that placed heavy pressure on the company after its acquisition of Monsanto in 2018. For claimants, the agreement may offer the prospect of payment. The terms determine who qualifies for compensation. The central question is therefore not only how much money will become available, but also how much uncertainty the arrangement actually removes.
Also show the region and a close-up
Both sides of the figures
▲ Bright spots
- Bayer gains greater predictability because payments will be spread over up to 21 years, according to the quarterly report.
- The settlement may offer thousands of claimants a fixed route to compensation, according to Associated Press.
▼ Concerns
- The obligation could rise to 7.25 billion dollars and comes on top of previous Roundup provisions.
- Up to 600 million dollars of the fund is earmarked for legal fees.
Critical note
The amount is a legal settlement, not established damage caused by Roundup. The assessments use different frameworks: IARC classified glyphosate as probably carcinogenic, while the EPA found no concerning cancer risk in its 2017 assessment.
Who notices what
- Businesses
- Bayer and agricultural companies gain greater clarity about legal costs and product policy in the United States.
- Households
- US participants in the scheme may receive compensation, but the amount will depend on personal circumstances and the programme rules.
- Investors
- The settlement may reduce some of the uncertainty surrounding Bayer, but entails long-term payments.
Every point comes from the article’s sources and was included in the fact check.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The article’s central claims are confirmed by Associated Press and Bayer. The scientific contrast was checked against the EPA and IARC and is presented as a difference in assessment frameworks.
- confirmed A judge in Missouri approved a Roundup settlement worth up to 7.25 billion dollars on 20 November 2026. — Associated Press describes the approval and the maximum amount. source
- confirmed The payments may last for up to 21 years. — Bayer reports declining payments over a period of up to 21 years. source
- confirmed Average compensation ranges from 10,000 to 165,000 dollars. — Associated Press gives this range and the factors affecting the amount. source
- confirmed The settlement includes up to 600 million dollars in legal fees. — This amount appears in AP’s summary of the court’s ruling. source
- confirmed The EPA found no concerning cancer risk in 2017. — The EPA page describes the 2017 assessment. source
- confirmed IARC classified glyphosate in 2015 as probably carcinogenic to humans. — IARC lists the classification as Group 2A. source
- confirmed In June, the US Supreme Court restricted the scope for claims concerning missing cancer warnings. — Associated Press describes the legal consequences of the ruling. source
Editor's note
It is certain that a judge in Missouri approved the settlement on 20 November 2026. The exact payment per participant and the final implementation may still change as a result of appeals and the programme’s conditions.Sources
- Court approves $7.25 billion settlement with Bayer over claims Roundup weed killer caused cancer — Associated Press
- Bayer Quarterly Statement as of September 30, 2026 — Bayer
- Glyphosate — U.S. Environmental Protection Agency
- Glyphosate Monograph now available — IARC
- Managing the Roundup Litigation — Bayer
More on this in Dutch media
- NU.nl — „bayer roundup”
- De Telegraaf — „bayer roundup”
- Trouw — „bayer roundup”